Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Cash from Financing Activities: 2022-2025

Historic Cash from Financing Activities for Prokidney (PROK) over the last 4 years, with Sep 2025 value amounting to $8.0 million.

  • Prokidney's Cash from Financing Activities rose 78.66% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year decrease of 94.02%. This contributed to the annual value of $144.4 million for FY2024, which is 1611.97% up from last year.
  • Per Prokidney's latest filing, its Cash from Financing Activities stood at $8.0 million for Q3 2025, which was up 56,964.29% from -$14,000 recorded in Q2 2025.
  • In the past 5 years, Prokidney's Cash from Financing Activities ranged from a high of $507.5 million in Q3 2022 and a low of -$9.5 million during Q4 2023.
  • Its 3-year average for Cash from Financing Activities is $13.0 million, with a median of -$13,000 in 2024.
  • In the last 5 years, Prokidney's Cash from Financing Activities tumbled by 118,800.00% in 2023 and then surged by 1,075,807.69% in 2024.
  • Prokidney's Cash from Financing Activities (Quarterly) stood at -$8,000 in 2022, then plummeted by 118,800.00% to -$9.5 million in 2023, then soared by 101.29% to $123,000 in 2024, then soared by 78.66% to $8.0 million in 2025.
  • Its last three reported values are $8.0 million in Q3 2025, -$14,000 for Q2 2025, and -$12,000 during Q1 2025.